Precautions and Warnings With Propranolol Sustained-Release

An awareness of propranolol sustained-release warnings and precautions can help identify situations in which the drug should not be taken. Conditions to discuss with your doctor before beginning treatment include depression, glaucoma, and chronic obstructive pulmonary disease. People who should not take the drug include those with a slow heartbeat, asthma, or allergies to it.

Propranolol Sustained-Release Drug Info

Propranolol Sustained-Release: What Should I Tell My Healthcare Provider?

You should talk with your healthcare provider prior to taking

propranolol hydrochloride sustained-release (Inderal^® LA) if you have:

Heart disease, including congestive heart failure, a history of heart attack, or irregular heart rhythm
Wolff-Parkinson-White syndrome
A slow heart rate
Asthma
Chronic obstructive pulmonary disease (COPD)
Kidney disease, such as kidney failure (renal failure)
Liver disease, including cirrhosis, hepatitis, or liver failure
Diabetes
Depression
Pheochromocytoma
Psoriasis
Glaucoma
Hyperthyroidism
Raynaud's phenomenon or other circulation problems
A blood vessel disease
Any allergies, including allergies to other beta blockers, foods, dyes, or preservatives.

Also, let your healthcare provider know if you:

Are pregnant or trying to become pregnant
Are breastfeeding
Smoke
Drink alcohol
Will be undergoing surgery or anesthesia.

Tell your healthcare provider about all other medicines you are currently taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.

(The information in this article applies specifically to Inderal LA and its generic versions. For information about InnoPran XL^®, a similar medication, see InnoPran XL.)

(Precautions and Warnings With Propranolol Sustained-Release Continued: Page 2)